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ess: rcostello@rcsi.ie (RSummary The principals of rehabilitation medicine are to prevent muscle atrophy
and improve mobility. Exacerbations of chronic obstructive pulmonary disease
(COPD) are associated with muscle atrophy and yet many patients do not undergo
pulmonary rehabilitation until they have been in stable health for some time. We
investigated the outcome of a supervised home exercise programme initiated
immediately after hospitalisation for an exacerbation of COPD. Thirty-one patients
were randomised into an exercise group (n ¼ 16; FEV1 0.9470.34 L) and a control
group (n ¼ 15; FEV1 1.0870.33 L). The exercise group received a twice-weekly
supervised exercise programme, in their homes, for 6 weeks. Spirometry, exercise
capacity, isometric muscle strength, dyspnea level, quality of life at baseline and 6
weeks as well as subsequent exacerbations were quantified. At 6 weeks, the exercise
group, improved the shuttle walk test (198m795–3047136m) and increased 3min
step test capacity (119740–163726 s) (both Po0:001). Knee extensor muscle
strength and quality of life scores also increased. Neither exercise capacity nor
muscle strength altered in the control group. Follow-up at 3 months showed that
three of the control group and none of the exercise group had experienced
subsequent exacerbations (P ¼ 0:06). Early rehabilitation via a home from hospital
programme improved exercise tolerance, muscle strength, dyspnea scores, quality
of life in COPD patients and reduced the number of subsequent exacerbations.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
8093762.
.W. Costello).Background
Chronic obstructive pulmonary disease (COPD) is
a common clinical condition characterised byed.
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tion. In advanced disease exacerbations are fre-
quent, average 2.4 for COPD patients per year, and
are associated with a reduction in quality of life.1
Numerous studies have confirmed that the use of
steroids and bronchodilators have an overall ben-
eficial effect on the rate of recovery of patients
who are admitted with acute exacerbations of
COPD.2–6 Nonetheless exacerbations of COPD are
associated with a delay in recovery of lung function
for up to 12 weeks and during this period there is a
risk of further exacerbations.7 The increase in risk
of further exacerbations during the recovery from a
COPD exacerbation is due to a variety of reasons
including weight loss, a negative nitrogen balance
leading to impaired host defence and inactivity
with subsequent deconditioning. Strategies to
improve this later component may lead to reduced
exacerbations and improved quality of life.
Pulmonary rehabilitation has been shown to be
an effective method for improving both quality of
life and for reducing exacerbations.8 However, the
majority of rehabilitation studies only include
COPD patients who have not experienced an
exacerbation for at least 2 months.9–11 Clinical
experience suggests that many patients who may
benefit from rehabilitation often miss out because
of repeated exacerbations. Many respiratory cen-
tres have initiated home therapy for exacerbations
of COPD, these have been shown to be safe,
beneficial and well regarded by patients.12,13 Since
early rehabilitation seems appropriate and since a
home from hospital exercise programme is a safe
means of treating patients, we hypothesised that a
home exercise training programme, initiated im-
mediately after an exacerbation of COPD, may
improve long-term outcomes for patients. This pilot
study was designed to evaluate whether a simple
supervised home-based programme initiated im-
mediately after a home from hospital-treated COPD
exacerbation, led to improved exercise capacity
and reduced exacerbations.Methods
Subjects
This was a prospective, controlled and randomised
study. Thirty-one consecutive patients admitted to
a COPD home from hospital treatment programme
were selected for the study. Subjects had moderate
to severe COPD (FEV1o60%) and a long history of
cigarette smoking. Subjects were excluded if they
had congestive heart failure, pneumonia, pneu-mothorax, pleural effusion, pulmonary embolism,
and arrhythmia.12 A COPD exacerbation was de-
fined as an increase in breathlessness, wheezing,
cough and a change in sputum colour and tenacity.
The study was approved by the Beaumont Hospital
Ethics (Medical Research) Committee and informed
consent was obtained from each subject. Measure-
ments (see below) were made in the hospital on the
day of discharge from hospital and at 6 weeks post-
exacerbation. Following initial testing, each pa-
tient was randomly assigned in a 1:1 ratio for the
home exercise group or a control group (standard
care group) using blinded sealed envelopes. Those
in the control group were referred for assessment
to the hospital’s outpatient pulmonary rehabilita-
tion programme, if they desired, after the study.
Seven of this control group subsequently attended.Exercise group
A chartered physiotherapist visited the subject’s
home, twice a week for 6 consecutive weeks to
supervise the home exercise programme. Each
subject received 12 supervised exercise sessions
in total. The exercise sessions lasted 30–40min
including rests. The patient was given a home
exercise diary and was instructed to exercise for at
least 15min on the other days. Aerobic exercises,
which required no equipment, included stepping up
and down a stair and sitting to standing from a
chair. Upper limb muscle groups were exercised
using a Thera-Band s. The Thera-Band s provides a
low-impact elastic resistance, with force produc-
tion dependent on the percent elongation of the
band. Symptom-limited exercise training was
used.14 Patients were trained between 3 and 5 on
the Borg breathlessness score (moderate to se-
vere). Resting oxygen saturation, HR and BP were
checked and recorded before each session.Control group
Subjects in the control group received their
standard medical treatment without any form of
rehabilitation exercises or lifestyle changes advice.Outcome measurements
Pulmonary function tests: Pulmonary function
testing for the determination of FEV1 and FVC was
performed in the sitting position using a spirometer
(Microlab ML 3500, Kent, England) according to
standard techniques.15
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Shuttle walk test (SWT) and 3min step test: Each
patient performed the incremental SWT. The test
was ended if the patient became too breathless to
maintain the required speed, if the patient did not
reach the cone in time after one chance to do so, if
the oxygen saturation became o85%, or the
patient wished to stop. The number of shuttles
walked was recorded.
Three minute step test: Subjects stepped up and
down a 15 cm step, at a stepping rate of 40 per min
for 3min, as controlled by the metronome.16
Subjects stopped if they were too breathless or
too tired to continue or the oxygen saturation fell
below 85%. The total time that they stepped for
was recorded, if they did not reach the 3min.
Oxygen saturation, heart rate and Borg score were
recorded before, during and at the end of the test.Strength measurements
Maximal voluntary isometric contraction (MVIC):
MVIC of bilateral knee extensors and bilateral
handgrip were measured using the quantitative
muscle assessment system (Qbitus products, West
Yorkshire, UK). This includes an electronic strain
gauge and Jamar hand dynamometer. The max-
imum value of three trials on each muscle group
was recorded. The subject was asked to maximally
push or squeeze against the strain gauge or hand
dynamometer, respectively, until the investigator
saw a peak in the contraction on the computer
screen. A rest of 3–4 s was given between trials.
Standardised verbal encouragement was given
during each test.
Dyspnoea evaluation: At rest before exercise and
after exercise cessation, the subjects were asked
to point to the Borg scale, to rate the magnitude of
their perceived breathlessness. In addition, the
Medical Research Council (MRC) dyspnea scale was
used. Subjects were asked about their perceived
breathlessness and were asked to grade themselves
from 0 to 4 on initial assessment and on retesting at
6 weeks.
Quality of life: Quality of life was measured using
the St. George’s respiratory questionnaire (SGRQ) a
disease-specific, self-administered quality of life
questionnaire. The subjects also completed the
EuroQol EQ-5D.17 The EuroQol defines health status
in terms of five dimensions: mobility, self-care,
usual activities (work, study, housework, family or
leisure), pain or discomfort, and anxiety and
depression. It also records a patient’s perception
of their overall health on a visual analogue scale (0denoting the worst imaginable health state and 100
denoting the best health state).
Statistical analysis
Data are presented as mean7standard deviation.
The level of significance was set at Po0:05:
Student’s paired t-test was used for pre- and
post-subject changes for interval/ratio data (SWT,
3min step test, EuroQol Thermometer, heart rate,
SpO2, lung function and strength measurement)
after checking for normal distribution. The Wilcox-
on non-parametric test was used for pre- and post-
subject data for the Borg, MRC, SGRQ and EuroQol
5Q. The within and between group differences
were analysed using repeated measures analysis of
variance. Comparison of the number of admissions
was using Fischer’s test.Results
A total of 31 patients were enrolled in the study, of
these 26 completed the study. Three from the
exercise group did not complete the study: 1 due to
an admission with an exacerbation, 1 suffered a
fracture sternum in a car accident and 1 went on a
holiday. Two from the control group did not
complete: 1 due to a hospital admission with an
exacerbation and 1 declined further participation.
The characteristics of these five were not different
from those of the remaining patients. The general
characteristics of the remaining patients in the two
groups before training are presented in Table 1.
There were no significant differences between the
groups in the baseline characteristics.
Exercise capacity
There was a significant improvement in the level of
dyspnea, at rest, as measured by the MRC scores in
both groups compared to baseline, see Table 2.
There was a significant improvement in exercise
capacity after training in the exercise group, the
distance walked improved by 106m compared to
baseline and the 3min step increased from 119 to
163 s (both Po0:001). In contrast, there was no
improvement in SWT or 3min step test in the
control group, see Table 2.
Effects of exercise on quality of life
There was a significant improvement in the EuroQol
scores in the exercise group from baseline to
post-training at 6 weeks (Po0:05) and a slight
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Table 1 Baseline characteristics of the study population.
Exercise group, n ¼ 13 Control group, n ¼ 13
Age (years) 6779.7 65711
Range 54–83 47–81
Gender 7 Male/6 female 10 Male/3 female
Current smoker 5 (38%) 4 (31%)
Pack year smoking history 73730 52730
Range 50–126 25–100
BMI (kg/m2) 2373.6 26.175.1
Previous hospitalisations in previous 12 months 2.171.7 1.771.95
Range 0–6 0–5
Length of stay on current admission 3–7 days 2–7 days
Home nebuliser 9 (69%) 8 (62%)
Long-term oxygen therapy 1 1
FEV1 (L) 0.9470.34 1.0870.33
FEV1 (% pred) 38712 42712
Resting heart rate (per min) 91715 90711
Resting SpO2% 9473 9672
Resting Borg 0.270.6 0.571.1
BMI: body mass index; FEV1: forced expiratory volume in 1 s; % pred: percentage of the predicted value; HR: heart rate; SpO2:
arterial oxygen saturation measured by pulse oximetry. None of these values are significantly different.
Table 2 Effects of exercise training on dyspnea and exercise capacity, assessed by shuttle walk test and the
3min step test.
Exercise group Control group
Baseline 6 weeks Baseline 6 weeks
Dyspnea
Resting Borg score 0.270.6 0.170.32 NS 0.571.1 0 NS
MRC scale 3.171.1 1.870.92 Po0:05 2.871.13 1.870.92 Po0:05
Shuttle walk test (m) 198795 3047136 Po0:001 2057189–750 2157185 NS
Range 50–320 100–540 50–750 50–750
SWT Borg 572 472 NS 472 4.471.7 NS
SWT HR 107716 102736 NS 117714 117717 NS
SWT SpO2 8974.77 9172.6 NS 9175.1 9174.7 NS
3min step test 119741 163726 Po0:001 129750 131744 NS
Range 1–3min 2–3min 1–3min 1–3min
Step test Borg 5.572.55 4.971.76 NS 5.173.24 5.373.6 NS
Step test HR 112713 116713 NS 118.8715 113710 NS
Step test SaO2 8974.1 9173 NS 9174 9173 NS
SWT: shuttle walk test, NS: not significant.
N. Murphy et al.1300non-significant decline in the control group, with
the EuroQol scores lower than baseline
(0.7470.16) at 6 weeks (0.6770.2), see Table 3.
The total scores for the SGRQ health status
measurement significantly improved (Po0:05) in
both groups from baseline, see Table 3. There was a
mean reduction of 18 units in the exercise group
and only a 9-unit reduction in the control group.
Patients in the exercise group showed a clinicallysignificant improvement in the impacts and activ-
ities components of the questionnaire (Po0:05).Muscle strength
There was no significant improvement in muscle
strength following the 6-week training programme
in either group. However, in the exercise group,
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Table 3 Effects of exercise training on quality of life scores, assessed by The St. George’s quality of life score
and the EuroQol life score.
Variables Exercise group mean value Control group mean value
Baseline 6 weeks Baseline 6 weeks
EuroQol 5D 0.770U23 0.8170U15 Po0:05 0.7470U16 0.6770U2 NS
EuroQol thermometer 62720U8 79712U6 Po0:05 62718 69727 NS
SGRQ—total 70.2714U2 52.4715 Po0:05 65.3717 56.5724 Po0:05
Symptoms 72.4713 7479U2 NS 74.9716 67.2717U3 NS
Impacts 63717U7 43.7714 Po0:05 44.7720 41.7725.6 NS
Activities 81740 55.7723 Po0:05 63.1720 52.4729 NS
NS: not significant.
Extending a home for COPD exacerbations 1301there was an improvement in left (5.73 kg, 38%) and
right (4.38 kg, 25%) knee extension strength, and a
1 kg improvement in hand grip after training. The
control group demonstrated no clinical improve-
ment at all with a reduction of 1–2 kg in lower-limb
knee extension strength at 6 weeks.
Exacerbations of COPD
At 3-month follow-up, three of the control group
and none of the exercise group had experienced a
subsequent exacerbation of COPD (P ¼ 0:06). At 6
months, 5 of the control group and 2 of the active
group had exacerbations (P ¼ 0:1), while not
statistically significant this is a trend.Discussion
The results of this study show that a supervised
home aerobic and a light resistance strength
training programme led to an improvement in
exercise capacity a reduction in dyspnoea at 6
weeks and improved quality of life scores also
significantly improved from baseline. There was a
trend towards increased muscle strength although
this was not statistically significant due in part to
the small numbers in the study and perhaps
inadequate strength training stimulus and duration.
Furthermore on follow-up, this benefit was asso-
ciated with a reduction in subsequent exacerba-
tions of COPD. Thus, this early intervention is a safe
and well-tolerated modality with valuable out-
comes.
The principle of general rehabilitation medicine
is that early intervention prevents muscle atrophy
and improves mobility. However, the majority of
exercise training, pulmonary rehabilitation pro-
grammes and studies only include COPD patientswho have been in a stable phase of their disease,
usually meaning no exacerbation, for at least 2
months. The reasoning for this is that meaningful
interpretation of changes can only be related to a
stable cohort. However, enforced rest, corticoster-
oid treatment and ongoing systemic and local
inflammation which can persist for several weeks
after an exacerbation lead to decreased exercise
tolerance, reduced QoL and enhanced chances of
further exacerbation. The aim of this study was to
start rehabilitation of patients with COPD as soon as
possible after an exacerbation. The results of this
study while preliminary, suggest that intervention
with rehabilitation as early as possible is useful for
patients with COPD.
The improvement in exercise capacity reported
in this study is similar to other home exercise and
pulmonary rehabilitation studies in the literature
though the latter were obtained through rather
complex rehabilitation programmes.18–21 By con-
trast, the current study has demonstrated that
even a relatively short period of home-based
training can improve exercise capacity to the same
extent as is achieved with much more complex
clinic-based programmes. Several factors may have
contributed to the improvement seen in this study.
One of these was the continual twice weekly
supervision by a trained respiratory physiotherapist
who monitored each patient’s progress, reassured
them that it was normal to be breathless while
exercising and ensured that they exercised for at
least 30min twice a week. The patients received
individual personal training and a carer was shown
the exercises so that they could assist the patient
exercising on the other days. A second contribution
to the improvement was the fact that the training
protocol was designed to match physical activities
that were routine for the patient population; that
is, the principle of task specificity was used. Finally,
the fact that the training was initiated soon after
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decline in muscle strength and exercise capacity,
as was seen in the control group.
The patients in the exercise group reported a
greater improvement in the total score of the SGRQ
and lower scores in the subsection impacts and
activities components indicating lower disability
levels than the control group. This may be due to
the fact that the exercise programme made the
patients more self-sufficient and helped them to
break the circle of inactivity and deterioration of
functional capacity which results in a greater
dyspnea at a given level of activity.
Only two patients in the exercise group were
admitted to hospital with an exacerbation of COPD
compared to five patients in the control group in
the 6 months following the study. While these data
are preliminary, they suggest that there may be
economic as well as practical benefits from this
approach. Further clinical studies will be required
to directly confirm this observation.
In summary, this study suggests that it is possible
to design and perform an immediate home exercise
programme following an exacerbation of COPD.
This programme seems to fit within a home from
hospital programme for exacerbations of COPD.
The results of this study suggest that such a
programme provides both objective and subjective
improvements in a variety of measures of health in
patients with COPD and may also reduce further
exacerbations.References
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